SAI LIFE SCIENCES LIMITED Share Price
SAI LIFE SCIENCES LIMITED Share Price Today
As of 25 Jul 2026, SAI LIFE SCIENCES LIMITED share price is ₹1,232.90. The stock opened at ₹1,225.40, compared to its previous close of ₹1,240.30. During today's trading session, SAI LIFE SCIENCES LIMITED share price moved in the range of ₹1,223.80 to ₹1,242.30, with an average price of ₹1,233.05 for the day. Looking at its last 52-week, the stock has touched a low of ₹778.50 and a high of ₹1,300.00. On the performance front, SAI LIFE SCIENCES LIMITED share price has increased by 55.08% over the last six months and is up 49.35% on a year-on-year basis.
SAI LIFE SCIENCES LIMITED Returns Calculator
SAI LIFE SCIENCES LIMITED Shareholder Returns
SAI LIFE SCIENCES LIMITED Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,65,711.00 | 36.73 | 5.05 | 14.85% | 0.55 | 18.72% | 18.85 | 0.91% | 0.56 | 10.90 |
| Divis Laboratories | 1,93,860.00 | 61.36 | 9.40 | 16.19% | 0.00 | 21.00% | 9.43 | 0.50% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,92,687.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,12,593.00 | 33.55 | 3.27 | 11.27% | 0.00 | 14.95% | 423.36 | 0.93% | 0.44 | 43.52 |
| Zydus Lifesciences | 1,11,082.00 | 17.39 | 3.23 | 19.69% | 0.35 | 20.30% | 3.70 | 0.11% | 0.39 | 35.38 |
| Lupin | 1,09,553.00 | 19.83 | 4.71 | 27.01% | 0.03 | 27.44% | 3.51 | 0.78% | 0.61 | 129.18 |
| Mankind Pharma | 1,05,607.00 | 1.05 | 0.12 | 12.65% | 0.42 | 12.97% | 5.05 | 0.05% | 0.54 | 49.37 |
| Dr. Reddy's Laboratories | 96,204.70 | 30.22 | 2.53 | 11.07% | 0.18 | 12.54% | 377.96 | 0.69% | 0.41 | 38.68 |
| Aurobindo Pharma | 88,508.40 | 25.27 | 2.34 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 84,727.30 | 60.26 | 10.10 | 18.21% | 0.40 | 16.70% | 97.21 | 0.12% | 0.64 | 13.72 |
SAI LIFE SCIENCES LIMITED Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹1,694.57 | ₹1,465.18 | ₹1,217.14 | ₹869.59 |
| Other Income | ₹36.78 | ₹29.09 | ₹27.97 | ₹28.15 |
| Total Revenue | ₹1,731.35 | ₹1,494.27 | ₹1,245.11 | ₹897.74 |
| Total Expenses | ₹1,503.65 | ₹1,385.04 | ₹1,228.70 | ₹888.05 |
| Profit Before Tax | ₹227.70 | ₹109.23 | ₹16.41 | ₹9.70 |
| Tax | ₹57.57 | ₹26.43 | ₹6.42 | ₹3.47 |
| Profit After Tax | ₹170.13 | ₹82.81 | ₹9.99 | ₹6.23 |
| EPS - Basic | ₹8.83 | ₹4.57 | ₹0.55 | ₹3.56 |
| EPS - Diluted | ₹8.61 | ₹4.53 | ₹0.55 | ₹3.50 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹227.70 | ₹109.23 | ₹16.41 | ₹9.70 |
| Income before WC changes | ₹466.77 | ₹315.20 | ₹188.56 | ₹138.84 |
| Change in Assets | -₹284.74 | -₹11.70 | ₹5.13 | -₹83.17 |
| Change in Liabilities | ₹153.65 | -₹26.54 | ₹29.80 | ₹57.32 |
| Change in WC | -₹131.09 | -₹38.24 | ₹34.93 | -₹25.85 |
| Cash flow from Operations | ₹314.05 | ₹263.09 | ₹219.40 | ₹104.87 |
| Cash flow from Investing | -₹536.67 | -₹192.38 | -₹101.78 | -₹103.71 |
| Cash flow from Financing | ₹301.43 | -₹95.30 | -₹200.65 | ₹71.92 |
| Total Cash Flow | ₹78.81 | -₹24.59 | -₹83.03 | ₹75.15 |
| Cash (Start of the year) | ₹11.97 | ₹35.53 | ₹115.78 | ₹40.62 |
| Cash (End of the year) | ₹91.05 | ₹11.97 | ₹35.53 | ₹115.77 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹1,655.46 | ₹1,330.02 | ₹1,222.70 | ₹1,213.14 |
| Current Assets | ₹1,504.51 | ₹945.11 | ₹963.95 | ₹944.20 |
| Total Assets | ₹3,159.98 | ₹2,275.14 | ₹2,186.65 | ₹2,157.35 |
| Current Liabilities | ₹732.49 | ₹739.90 | ₹758.85 | ₹713.42 |
| Net Current Asset | ₹772.02 | ₹205.21 | ₹205.10 | ₹230.78 |
| Non-Current Liabilities | ₹299.13 | ₹560.09 | ₹539.70 | ₹565.36 |
| Equity Capital | ₹2,128.35 | ₹975.14 | ₹888.09 | ₹878.57 |
| Total Equity & Liabilities | ₹3,159.98 | ₹2,275.14 | ₹2,186.65 | ₹2,157.35 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹1,642.05 | ₹1,418.68 | ₹1,157.40 | ₹841.02 |
| Other Income | ₹37.34 | ₹29.33 | ₹27.96 | ₹28.15 |
| Total Revenue | ₹1,679.38 | ₹1,448.01 | ₹1,185.36 | ₹869.17 |
| Total Expenses | ₹1,447.67 | ₹1,319.01 | ₹1,152.68 | ₹846.82 |
| Profit Before Tax | ₹231.72 | ₹129.01 | ₹32.69 | ₹22.35 |
| Tax | ₹58.25 | ₹33.77 | ₹8.45 | ₹6.67 |
| Profit After Tax | ₹173.46 | ₹95.23 | ₹24.24 | ₹15.68 |
| EPS - Basic | ₹9.00 | ₹5.26 | ₹13.42 | ₹8.97 |
| EPS - Diluted | ₹8.78 | ₹5.21 | ₹13.29 | ₹8.82 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹231.72 | ₹129.01 | ₹32.69 | ₹22.35 |
| Income before WC changes | ₹452.11 | ₹315.04 | ₹186.76 | ₹132.29 |
| Change in Assets | -₹267.98 | -₹27.51 | ₹18.97 | -₹91.48 |
| Change in Liabilities | ₹167.70 | -₹23.39 | ₹19.82 | ₹55.68 |
| Change in WC | -₹100.28 | -₹50.90 | ₹38.79 | -₹35.80 |
| Cash flow from Operations | ₹330.35 | ₹250.64 | ₹221.47 | ₹88.38 |
| Cash flow from Investing | -₹564.71 | -₹190.05 | -₹111.23 | -₹94.63 |
| Cash flow from Financing | ₹314.31 | -₹84.63 | -₹190.04 | ₹80.95 |
| Total Cash Flow | ₹79.95 | -₹24.04 | -₹79.80 | ₹74.70 |
| Cash (Start of the year) | ₹5.17 | ₹29.21 | ₹109.01 | ₹34.31 |
| Cash (End of the year) | ₹85.12 | ₹5.17 | ₹29.21 | ₹109.01 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹1,642.12 | ₹1,288.75 | ₹1,178.69 | ₹1,162.23 |
| Current Assets | ₹1,494.54 | ₹951.17 | ₹951.93 | ₹943.66 |
| Total Assets | ₹3,136.66 | ₹2,239.92 | ₹2,130.62 | ₹2,105.89 |
| Current Liabilities | ₹727.20 | ₹723.24 | ₹739.36 | ₹707.57 |
| Net Current Asset | ₹767.35 | ₹227.93 | ₹212.57 | ₹236.09 |
| Non-Current Liabilities | ₹242.00 | ₹505.48 | ₹478.53 | ₹507.29 |
| Equity Capital | ₹2,167.46 | ₹1,011.20 | ₹912.73 | ₹891.04 |
| Total Equity & Liabilities | ₹3,136.66 | ₹2,239.92 | ₹2,130.62 | ₹2,105.89 |
About SAI LIFE SCIENCES LIMITED
Sai Life Sciences Limited is an India-based contract research, development, and manufacturing organization (CRO/CDMO). The Company carries out contract research and manufacturing activities for customers engaged in pharmaceutical and biotechnology industries. It is engaged in offering a range of services tailor-made to the customer's requirements. It provides discovery and chemistry, manufacturing, and controls (CMC) services that span from drug discovery to process development and early-phase supplies, all the way to commercial launch and life cycle management. Its services include Integrated Drug Discovery, Synthetic & medicinal chemistry, Biology, drug metabolism and pharmacokinetics (DMPK), Genotoxicity, General Toxicology and Computational chemistry. Its CMC services include route scouting; process development; analytical development; process safety; stability studies; early and mid-phase supplies; late phase, commercial manufacturing; technology transfer, and technologies.
SAI LIFE SCIENCES LIMITED Financial Highlights
- Revenue: SAI LIFE SCIENCES LIMITED reported revenue of ₹2,241.62 crore in FY26 vs ₹1,731.35 crore in FY25. It showed an increase of 29.47% on a yearly basis.
- Operating Profit: SAI LIFE SCIENCES LIMITED reported an operating profit of ₹466.19 crore in FY26 vs ₹227.70 crore in FY25. It showed an increase of 104.74% on a year-on-year basis.
- Net Profit: SAI LIFE SCIENCES LIMITED reported a net profit of ₹348.91 crore in FY26 vs ₹170.13 crore in FY25. It showed an increase of 105.08% on a yearly basis.
SAI LIFE SCIENCES LIMITED Quarterly Result Highlights
- SAI LIFE SCIENCES LIMITED reported revenue of ₹617.66 crore in Mar 2026, compared with ₹564.84 crore in Dec 2025, representing an increase of 9.35% on a quarter-on-quarter (QoQ) basis.
- SAI LIFE SCIENCES LIMITED reported an operating profit of ₹139.23 crore in Mar 2026, compared with ₹134.17 crore in Dec 2025, representing an increase of 3.77% on a quarter-on-quarter (QoQ) basis.
- SAI LIFE SCIENCES LIMITED reported a profit of ₹104.24 crore in Mar 2026, compared with ₹100.38 crore in Dec 2025, reflecting an increase of 3.85% on a QoQ basis.
- The earnings per share (EPS) of SAI LIFE SCIENCES LIMITED stood at ₹8.83 during Mar 2026.
Similar Stocks
FAQs on SAI LIFE SCIENCES LIMITED Share Price
What is SAI LIFE SCIENCES LIMITED share price today?
SAI LIFE SCIENCES LIMITED share price is ₹1,232.90 as on 24 Jul, 2026, 15:45 IST.
How has the SAI LIFE SCIENCES LIMITED share price performed in the past?
In the last 1 year, SAI LIFE SCIENCES LIMITED delivered a return of 49.35%. The SAI LIFE SCIENCES LIMITED share price hit a high of ₹1,300.00 and low of ₹778.50.
How much is the Mutual Fund shareholding in SAI LIFE SCIENCES LIMITED shares?
The Mutual Fund Shareholding in SAI LIFE SCIENCES LIMITED was 29.47% at the end of Jun 2026.
What is the the 52-week high and low of SAI LIFE SCIENCES LIMITED shares ?
The 52-week high and low of SAI LIFE SCIENCES LIMITED share is ₹1,300.00 and ₹778.50 as of 24 Jul, 2026.
What is the market cap of SAI LIFE SCIENCES LIMITED?
The market capitalisation of SAI LIFE SCIENCES LIMITED is ₹26,327.80 Crores as on 24 Jul, 2026.
What are the stock symbols of SAI LIFE SCIENCES LIMITED?
The stock symbol of SAI LIFE SCIENCES LIMITED is SAILIFE on the NSE, 544306 on the BSE, and the ISIN is INE570L01029.
What was yesterday's closing price of SAI LIFE SCIENCES LIMITED shares ?
SAI LIFE SCIENCES LIMITED shares closed yesterday at ₹1,240.30 on NSE & ₹1,240.15 on BSE
How to buy SAI LIFE SCIENCES LIMITED shares?
To buy SAI LIFE SCIENCES LIMITED shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy SAI LIFE SCIENCES LIMITED shares on Holidays?
No, shares of SAI LIFE SCIENCES LIMITED or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell SAI LIFE SCIENCES LIMITED shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of SAI LIFE SCIENCES LIMITED?
The PE and PB ratio of SAI LIFE SCIENCES LIMITED is 74.96 and 10.53 respectively, as on 24 Jul, 2026, 15:45 IST.
